Epithelial to Mesenchymal Transition in a Clinical Perspective

Area of Science:

• Oncology
• Cell Biology
• Cancer Metastasis

Background:

• Tumor growth and metastasis depend on cancer cell plasticity.
• Epithelial to mesenchymal transition (EMT) confers increased mobility and invasiveness to cancer cells.
• EMT is linked to aggressive tumor phenotypes, local invasion, and distant metastasis.

Purpose of the Study:

• To review and analyze therapeutic strategies aimed at blocking EMT.
• To evaluate the current status of EMT inhibitors in preclinical and clinical settings.

Main Methods:

• Review of existing literature on EMT targeting therapies.
• Analysis of preclinical studies in animal models.
• Assessment of ongoing clinical trials for EMT inhibitors.

Main Results:

• Most studies on EMT inhibitors have been conducted in animal models.
• Few clinical trials are currently underway.
• No significant clinical benefits from EMT inhibitors have been observed yet.

Conclusions:

• Targeting EMT presents a promising therapeutic avenue for cancer.
• Significant challenges remain, including tumor heterogeneity and the dynamic nature of EMT.
• Further research is needed to overcome limitations and develop effective EMT-targeting therapies.